473 related articles for article (PubMed ID: 26650262)
1. Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways.
Ayers JI; Fromholt SE; O'Neal VM; Diamond JH; Borchelt DR
Acta Neuropathol; 2016 Jan; 131(1):103-14. PubMed ID: 26650262
[TBL] [Abstract][Full Text] [Related]
2. Experimental transmissibility of mutant SOD1 motor neuron disease.
Ayers JI; Fromholt S; Koch M; DeBosier A; McMahon B; Xu G; Borchelt DR
Acta Neuropathol; 2014 Dec; 128(6):791-803. PubMed ID: 25262000
[TBL] [Abstract][Full Text] [Related]
3. Distinct conformers of transmissible misfolded SOD1 distinguish human SOD1-FALS from other forms of familial and sporadic ALS.
Ayers JI; Diamond J; Sari A; Fromholt S; Galaleldeen A; Ostrow LW; Glass JD; Hart PJ; Borchelt DR
Acta Neuropathol; 2016 Dec; 132(6):827-840. PubMed ID: 27704280
[TBL] [Abstract][Full Text] [Related]
4. Progressive aggregation despite chaperone associations of a mutant SOD1-YFP in transgenic mice that develop ALS.
Wang J; Farr GW; Zeiss CJ; Rodriguez-Gil DJ; Wilson JH; Furtak K; Rutkowski DT; Kaufman RJ; Ruse CI; Yates JR; Perrin S; Feany MB; Horwich AL
Proc Natl Acad Sci U S A; 2009 Feb; 106(5):1392-7. PubMed ID: 19171884
[TBL] [Abstract][Full Text] [Related]
5. Endogenous macrophage migration inhibitory factor reduces the accumulation and toxicity of misfolded SOD1 in a mouse model of ALS.
Leyton-Jaimes MF; Benaim C; Abu-Hamad S; Kahn J; Guetta A; Bucala R; Israelson A
Proc Natl Acad Sci U S A; 2016 Sep; 113(36):10198-203. PubMed ID: 27551074
[TBL] [Abstract][Full Text] [Related]
6. Differential induction of mutant SOD1 misfolding and aggregation by tau and α-synuclein pathology.
Pace MC; Xu G; Fromholt S; Howard J; Giasson BI; Lewis J; Borchelt DR
Mol Neurodegener; 2018 May; 13(1):23. PubMed ID: 29776378
[TBL] [Abstract][Full Text] [Related]
7. Variation in the vulnerability of mice expressing human superoxide dismutase 1 to prion-like seeding: a study of the influence of primary amino acid sequence.
Ayers JI; Xu G; Dillon K; Lu Q; Chen Z; Beckman J; Moreno-Romero AK; Zamora DL; Galaleldeen A; Borchelt DR
Acta Neuropathol Commun; 2021 May; 9(1):92. PubMed ID: 34016165
[TBL] [Abstract][Full Text] [Related]
8. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD
Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389
[TBL] [Abstract][Full Text] [Related]
9. Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice.
Wang L; Gutmann DH; Roos RP
Hum Mol Genet; 2011 Jan; 20(2):286-93. PubMed ID: 20962037
[TBL] [Abstract][Full Text] [Related]
10. Spinal inhibitory interneuron pathology follows motor neuron degeneration independent of glial mutant superoxide dismutase 1 expression in SOD1-ALS mice.
Hossaini M; Cardona Cano S; van Dis V; Haasdijk ED; Hoogenraad CC; Holstege JC; Jaarsma D
J Neuropathol Exp Neurol; 2011 Aug; 70(8):662-77. PubMed ID: 21760539
[TBL] [Abstract][Full Text] [Related]
11. Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons.
Lasiene J; Komine O; Fujimori-Tonou N; Powers B; Endo F; Watanabe S; Shijie J; Ravits J; Horner P; Misawa H; Yamanaka K
Acta Neuropathol Commun; 2016 Feb; 4():15. PubMed ID: 26891847
[TBL] [Abstract][Full Text] [Related]
12. Mutant superoxide dismutase aggregates from human spinal cord transmit amyotrophic lateral sclerosis.
Ekhtiari Bidhendi E; Bergh J; Zetterström P; Forsberg K; Pakkenberg B; Andersen PM; Marklund SL; Brännström T
Acta Neuropathol; 2018 Dec; 136(6):939-953. PubMed ID: 30284034
[TBL] [Abstract][Full Text] [Related]
13. Multiple Factors Influence the Incubation Period of ALS Prion-like Transmission in SOD1 Transgenic Mice.
Ayers JI; Xu G; Lu Q; Dillon K; Fromholt S; Borchelt DR
Viruses; 2023 Aug; 15(9):. PubMed ID: 37766226
[TBL] [Abstract][Full Text] [Related]
14. Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis.
Pokrishevsky E; Grad LI; Yousefi M; Wang J; Mackenzie IR; Cashman NR
PLoS One; 2012; 7(4):e35050. PubMed ID: 22493728
[TBL] [Abstract][Full Text] [Related]
15. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
16. Degeneration of respiratory motor neurons in the SOD1 G93A transgenic rat model of ALS.
Lladó J; Haenggeli C; Pardo A; Wong V; Benson L; Coccia C; Rothstein JD; Shefner JM; Maragakis NJ
Neurobiol Dis; 2006 Jan; 21(1):110-8. PubMed ID: 16084734
[TBL] [Abstract][Full Text] [Related]
17. Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice.
Sheean RK; Weston RH; Perera ND; D'Amico A; Nutt SL; Turner BJ
J Neuroinflammation; 2015 Feb; 12():40. PubMed ID: 25889790
[TBL] [Abstract][Full Text] [Related]
18. Somatodendritic accumulation of misfolded SOD1-L126Z in motor neurons mediates degeneration: alphaB-crystallin modulates aggregation.
Wang J; Xu G; Li H; Gonzales V; Fromholt D; Karch C; Copeland NG; Jenkins NA; Borchelt DR
Hum Mol Genet; 2005 Aug; 14(16):2335-47. PubMed ID: 16000321
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
[TBL] [Abstract][Full Text] [Related]
20. Aberrant association of misfolded SOD1 with Na(+)/K(+)ATPase-α3 impairs its activity and contributes to motor neuron vulnerability in ALS.
Ruegsegger C; Maharjan N; Goswami A; Filézac de L'Etang A; Weis J; Troost D; Heller M; Gut H; Saxena S
Acta Neuropathol; 2016 Mar; 131(3):427-51. PubMed ID: 26619836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
